Keyword: Shockwave Medical
2015 Fierce 15 company Shockwave Medical is going public, filing for a $75 million IPO on the Nasdaq with the ticker symbol SWAV.
Shockwave's new financing will expand commercialization of its ultrasound balloon treatment for calcified artery disease and boost R&D.
A 20-patient study showed its ultrasound PAD balloon was effective in patients with arterial blockage below the knee.
The FDA cleared Ra Medical Systems’ catheter-and-laser atherectomy system for the treatment of peripheral artery disease.
Shockwave Medical, which markets a system that delivers ultrasound shockwaves to treat peripheral artery disease, has notched a CE mark for the treatment of coronary artery disease.
Shockwave Medical picked up $45 million in a Series C round, which will propel the development and commercialization of its ultrasound balloon device for the treatment of peripheral artery disease.
The FDA cleared Shockwave Medical’s angioplasty balloon that delivers ultrasound shockwaves to break up calcified plaques in patients with peripheral artery disease, the company announced Friday.